Search
for
Sort by
Community 15
- GT20029 - Promising phase II results
- Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
- FCE 28260: A Forgotten 5α-Reductase Inhibitor
- mallia therapeutics 8T3 scd83 molecule for ffa/lpp mainly and aga
- The Chinese version of Stemson Therapeutics (Hair Multiplication) is here. It is called Yunce Medical.
- Horrible news, Stemson Therapeutics has shut down
- Stemson Therapeutics Announces Technological Breakthrough in new Hair Growth
- IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia
- Pyrilutamide just launched internationally, and all you're doing is hating
- How to BECOME a RESPONDER to Fin/Dut if you are not responding
- Grey Market GT20029 and Frequency of Application
- How soon is hair clone? Next five years?!
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- Stem-cell hair transplants! 20k lab grown grafts from one single graft
- 2 % fucoidan significantly alleviated AGA symptoms, promoted hair growth, and increased hair density